Dear editor
I am writing this correspondence with the interest in an editorial, entitled “COVID-19 and Tuberculosis”, a viewpoint, entitled “Tuberculosis and COVID-19 in India – double trouble!”, and an article, entitled “The potential Impact of the COVID-19 response related lockdown on TB incidence and mortality in India” published in the journal which focuses mainly on COVID-19 and TB burden in India. The study by Bhargava and Shewade1 reported that COVID-19 outbreak had an impact on reduction in Tuberculosis (TB) detection, which further contributes to increased transmission reflect in increased incidence in later time period. In addition to information furnished, little is known about the specific impact of COVID-19 epidemic on TB, especially, during unlock period. Here, an attempt has been made to compare the actual epidemic real-time data on TB released daily by the NI-KSHYA web portal2 under union health ministry from March to August of 2019 and 2020.
The Prime Minister of India, in response to COVID-19 (Corona Virus Disease 2019) pandemic identified in China during December, 20193 , 4 and the first case was identified during January, 2020 in India,5 announced a ‘Janata Curfew’ on March 22, 2020; and subsequently, a nationwide lockdown was imposed from March 25, 2020.6 , 7 Vigorous infection control measures, such as testing, tracing, physical distancing and restrictions on movements, etc. were initiated.6 While this situation remains in effect, such measures could negatively affect the overall healthcare services for other necessary healthcare need, such as TB.8 TB, an oldest and more burdensome infectious killer, is still a public health crisis across the globe. India bears the highest TB burden in the world; a quarter of 10 million cases and one-third of 1.2 million deaths globally.9 Further, India has reported 24 Lakh TB cases in 2019; an increase of over 12% compared to 2018.10 On the other hand, the surge of COVID-19 cases is still continue, and as on September 23, 2020, 07:36 GMT almost 31.8 and 5.6 million confirmed COVID-19 cases have been reported across the world and in India, respectively.11 There is a crucial connection between TB and COVID-19; both the diseases show similar symptoms, such as fever, difficulty in breathing, cough; and transmitted through respiratory droplets and attack the lungs.12, 13, 14, 15 Moreover, both diseases can be identified using the same diagnostic technology/mechanism.12 , 13 , 15
Daily TB notification data extracted from NI-KSHAY2 web-portal of union Health Ministry demonstrates that since COVID-19 outbreak, especially during and after COVID-19 forced lockdown period, TB cases notifications has drastically decreased. At the national level, on an average daily 6–7 thousand TB cases were reported before lockdown during, which suddenly decreased to around 2k during first week of lockdown, and 2.5 and 3.8k during April and May months. Further, though, daily TB cases were increased to around 5k during June, than these numbers again decreased in succeeding months; around 4k and 3k during July and August months, respectively (Fig. 1 ).
Overall, in 2020, the national level monthly number of newly registered patient with TB from March to August months were 167,727, 82,249, 118,455, 152,656, 132,400 and 102,835, this represent a percentage decrease of 21%, 63%, 47%, 25%, 38% and 45%, respectively, compared to the same period in the previous year (Fig. 2 ). During overall lockdown period, total 224,450 TB cases were reported compared to 507,749 cases during the same period of 2019, a reduction of 56% and 283,299 less cases in absolute numbers. Similarly, during post-lockdown period (up to August 31, 2020), total 405,122 TB cases were reported compared to 643,522 cases during the same period of 2019, a reduction of 37% and 283,400 less cases in absolute numbers (Table 1 ).
Table 1.
Periodˆ | No. of TB notifications, 2019 | No. of TB notifications, 2020 | Absolute difference | Percentage Decrease |
---|---|---|---|---|
Pre-lockdown | 545,512 | 553,561 | (8049) | 1.5% |
Lockdown | 507,749 | 224,450 | 283,299 | −55.8% |
Post-lockdown | 643,522 | 405,122 | 238,400 | −37.0% |
Total | 1,696,783 | 1,183,133 | 513,650 | −30.3% |
Note: () figure in parenthesis is excess number of TB notifications during 2020 compared to 2019; ˆnationwide COVID-19 forced lockdown was imposed during March 25, 2020 to May 31, 2020. Hence, pre-lockdown period was considered form 1 January to 24 March, lockdown form 25 March to 31 May and post-lockdown from 1 June to 31 August; COVID-19, coronavirus disease; TB, tuberculosis.
Source: Author's calculations based on TB notifications data extracted from the NI-KSHAY database (NTEP 2020).
The more worrying aspect is the reduction in TB notification even during unlock period. The reported data illustrates that the TB cases reported is still substantially low even after lockdown was removed. Though, soon after lockdown was removed, some improvements were observed during June month (only 25% reduction in TB cases compared to same month in previous of 2019) but again the percentage decrease in TB notifications were increase in July (−38%) and August (−45%) months (Fig. 2). These trends demonstrate that the gap in newly registered TB cases was gradually widening month by month compared to previous year of 2019, which is more troublesome aspect in India. This is accompanied by surge in COVID-19 cases day-by-day (Fig. 1).
The entire healthcare concentration, including TB diagnostic technology/mechanism, is diverted to COVID-19 crises; leading to deprioritized and delayed in TB investigation.16 Moreover, patient with newly developed respiratory symptoms are scared to visit clinics.17 Conditionality on Private Doctors/Druggist was hampered healthcare services18; and even outpatient clinics and emergency departments were being temporarily closed after patients tested positive for COVID-19.19 Furthermore, it is being argued that the infection control measure imposed in response to COVID-19 will reflect in reduced TB infection.20 Hence, both, the lower number of new TB cases during COVID-19 epidemic due to delay in diagnosis and TB cases reduced by comprehensive measure in response to COVID-19 are the topics of further study. The nation-wide real-time TB registration data in coming days may provide a better answer.
In summary, though, the above reasons may have led to the reduction in the TB notifications, but it must be noted here that this may dampen the government of India's aim to eradicate TB by 2025. Hence, the continuity of essential TB interventions should be implemented simultaneously with response to COVID-19.
Availability of data and materials
The data used for the study is obtained from the NI-KSHAY web-portal under union health ministry which is available in public domain. No separate ethics statement and consent for publication was required for this study.
Conflicts of interest
The author has none to declare.
References
- 1.Bhargava A., Shewade H.D. The potential impact of the COVID-19 response related lockdown on TB incidence and mortality in India. Indian J Tubercul. 2020;67(4):S139–S146. doi: 10.1016/j.ijtb.2020.07.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.National Tuberculosis Elimination Programme (NTEP) 2020. India: NI-KSHAY Web-Portal Data Reports.https://reports.nikshay.in/Reports/TBNotification Available at: [Google Scholar]
- 3.Wang C., Horby P.W., Hayden F.G., Gao G.F. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–473. doi: 10.1016/S0140-6736(20)30185-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.World Health Organization (WHO) 2020. WHO Director-General's Remarks at the Media Briefing on 2019-nCoV on 11 February 2020.https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020 Available at: [Google Scholar]
- 5.Ministry of Health and Family Welfare (MoHFW) (internet) MoHFW; New Delhi: January 30 2020. Update on Novel Coronavirus: One Positive Case Reported in Kerala.https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1601095 1.33 PM, Release ID: 1601095, available at: [Google Scholar]
- 6.Ministry of Home Affairs (MoHA). Guidelines on the Measure to Be Taken by Ministers/Departments of Government of India . 2020. State/Union Territory Governments and State/Union Territory Authorities for Containment of COVID-19 Epidemic in the Country. New Delhi. [Google Scholar]
- 7.Pulla P. Covid-19: India imposes lockdown for 21 days and cases rise. BMJ. 2020;368:m1251. doi: 10.1136/bmj.m1251. [DOI] [PubMed] [Google Scholar]
- 8.Iyengar KP, and Jain VK. (internet). Tuberculosis and COVID-19 in India- double trouble!. Indian J Tubercul, Advance online publication. 10.1016/j.ijtb.2020.07.014. [DOI] [PMC free article] [PubMed]
- 9.World Health Organization (WHO) World Health Organization; Geneva: 2019. Global Tuberculosis Report.https://www.who.int/tb/publications/global_report/en/ Licence: CC BY-NC-SA 3.0 IGO. Available at: [Google Scholar]
- 10.Ministry of Health & Family Welfare (MoHFW) Central TB Division, Ministry of Health & Family Welfare, Government of India; New Delhi: 2020. India TB Report.https://tbcindia.gov.in/showfile.php?lid=3538 Available at: [Google Scholar]
- 11.Coronavirus Update (Live). 31,800,290 Cases and 975,769 Deaths from COVID-19 Virus Pandemic. Worldometer. Available at: https://www.worldometers.info/coronavirus/. (Accessed on 23rd September, 2020).
- 12.Ahn D.G., Shin H.J., Kim M.H. Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19) J Microbiol Biotechnol. 2020;30(3):313–324. doi: 10.4014/jmb.2003.03011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.World Health Organization (WHO) May 12 2020. Information Note: Tuberculosis and COVID-19.https://www.who.int/docs/default-source/documents/tuberculosis/infonote-tb-covid-19.pdf Available at: [Google Scholar]
- 14.Zhu N., Zhang D., Wang W. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi: 10.1056/NEJMoa2001017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Yang X., Yu Y., Xu J. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet. Respr Med. 2020;8(5):475–481. doi: 10.1016/S2213-2600(20)30079-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Pai M. COVID-19 coronavirus and tuberculosis: we need a damage control plan. Forbes. Mar 17 2020 https://www.forbes.com/sites/madhukarpai/2020/03/17/covid-19-and-tuberculosis-we-need-a-damage-control-plan/#f72dd45295caExternal Link Available at: [Google Scholar]
- 17.Dhawad P. the Times of India; August 5, 2020. Fear of Public Healthcare, High Medical Bills Stop People Going for COVID-19 Test.https://timesofindia.indiatimes.com/city/ludhiana/fear-of-public-healthcare-high-medical-bills-stop-people-from-going-for-covid-19-test/articleshow/77358011.cms Available at: [Google Scholar]
- 18.Pillai S. Hindustan Times; August 15 2020. Private Neighborhood Clinics Shut; Patients Struggle to Treat Minor Ailments.https://www.hindustantimes.com/cities/private-neighbourhood-clinics-shut-patients-struggle-to-treat-minor-ailments/story-JIUzCK17OnTZJwEe8XtycI.html Available at: [Google Scholar]
- 19.Kulkarni T. At least 300 hospitals contest department's claim that they are temporarily closed. Hindu. August 1 2020 https://www.thehindu.com/news/national/karnataka/at-least-300-hospitals-contest-departments-claim-that-they-are-temporarily-closed/article32244437.ece Available at: [Google Scholar]
- 20.Stop TB Partnership in collaboration with Imperial College; Avenir Health. Johns Hopkins University and USAID; Geneva, Switzerland.The Potential Impact of the COVID-19 Response on Tuberculosis in High-Burden Countries: A Modeling Analysis. Available at: http://www.stoptb.org/assets/documents/news/Modeling%20Report_1%20May%202020_FINAL.pdf. (Accessed on 9th September, 2020).
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data used for the study is obtained from the NI-KSHAY web-portal under union health ministry which is available in public domain. No separate ethics statement and consent for publication was required for this study.